Last Updated: November 10, 2026

CLINICAL TRIALS PROFILE FOR AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

« Back to Dashboard

All Clinical Trials for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00136851 ↗	Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension	Completed	Novartis Pharmaceuticals	Phase 4	2004-12-01	This trial is designed to study the efficacy of an amlodipine besylate/benazepril treatment regimen versus an amlodipine treatment regimen in the treatment of severe hypertension.
NCT01155895 ↗	Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Fasting Conditions	Completed	Dr. Reddy's Laboratories Limited	Phase 1	2004-03-01	The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Lotrel®) 10 mg amlodipine besylate/20 mg benazepril hydrochloride capsules, under fasting conditions.
NCT01155908 ↗	Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Non-fasting (Fed) Conditions	Completed	Dr. Reddy's Laboratories Limited	Phase 1	2005-04-01	The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Lotrel®) 10 mg amlodipine besylate/20 mg benazepril hydrochloride capsules, under non-fasting (fed) conditions.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

Condition Name

Chart
Table

Condition Name for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Intervention	Trials
Healthy	2
Hypertension	2
Fasting	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Intervention	Trials
Hypertension	2
Malnutrition	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

Trials by Country

Map
Table

Trials by Country for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Location	Trials
India	2
United States	1
China	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Location	Trials
New Jersey	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Clinical Trial Phase	Trials
Phase 4	2
Phase 1	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Clinical Trial Phase	Trials
Completed	5
Active, not recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

Sponsor Name

Chart
Table

Sponsor Name for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Sponsor	Trials
Dr. Reddy's Laboratories Limited	4
Novartis Pharmaceuticals	1
Shanghai Jiao Tong University School of Medicine	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Sponsor	Trials
Industry	5
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.